학술논문

ABCL-181: Updated Results of a Phase 2 Study from GELTAMO Investigating the Combination of Ibrutinib with R-GEMOX in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Document Type

Academic Journal

Author

Búa, Beatriz Rey; Ubieto, A Jiménez; Blanco, JJ Sánchez; Abrisqueta, P; Gutiérrez, A; Páyez, A Ramírez; Giné, E; Etxetxipia, I Zeberio; Terol, MJ; de la Cruz, F; Andreu, R.; Ramirez, MJ; de la Fuente, A; Viguria, MC; Peñarrubia, MJ; Grande, C.; Barrigón, MD Caballero; García-Sancho, A Martín

Source

Clinical Lymphoma, Myeloma & Leukemia (CLIN LYMPHOMA MYELOMA LEUKEMIA), 2021 Supplement 1; 21: S381-S381. (1p)

Subject

Language

English

ISSN

2152-2650

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송